Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Centessa Pharmaceuticals plc

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-23Mar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-Q10-Q8-K10-Q
Operating expenses:        
Research and development    116.480.8  
General and administrative    54.651.7  
Change in fair value of contingent value rights     17.1  
    Loss from operations    -218.2-191.1  
Interest income    -4.2-2.6  
Interest expense    -3.2-1.5  
Other (expense) income, net    3.6-1.9  
    Loss before income taxes    -119.1-54.4  
Income tax (benefit) expense    0.20.2  
    Net loss    -220.1-196.9  
   
Other comprehensive income (loss):        
Foreign currency translation adjustment    -2.3-0.1  
    Other comprehensive income (loss)    -1.1   
    Total comprehensive loss    -224.5-199.0  
   
Net loss per ordinary share - basic (in dollars per share)    ($1.74)($1.70)  
Net loss per ordinary share - diluted (in dollars per share)    ($1.74)($1.70)  
   
Weighted average ordinary shares outstanding - basic (in shares)    68.661.0  
Weighted average ordinary shares outstanding - diluted (in shares)    68.661.0  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy